Pure Global AI
NCT06149312Not yet recruiting

A Prospective, Randomized Trial Assessing the Feasibility of an Advance Care Planning Intervention

A Prospective, Randomized Trial Assessing the Feasibility of an Advance Care Planning Intervention for Patients Hospitalized in a French Cancer Center
Institut de cancérologie Strasbourg EuropeClinicalTrials.govother
Verified
Study focus
Disease/Condition
Neoplasms
Drug/Device/Intervention
Advance Care Planning Intervention
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Institut de cancérologie Strasbourg Europe
Location
Strasbourg, France
Timeline & enrollment
Phase
N/A
Start date
Dec 11, 2023
End date
Dec 11, 2024
Enrollment
120 participants
Primary outcome

Percentage of patients who write advance directives of living at 3 months

Summary

Advanced Cancer patients hospitalized in a Cancer center inpatient unit have a dismal
 prognosis. Palliative Care interventions have shown multiple benefit for those patients,
 regarding quality of life, symptom management, illness understanding and aggressiveness of
 care criteria. Although Advance Care planning (ACP) is part of usual Palliative Care,
 specific interventions dedicated to ACP are understudied.
 
 This study aims at showing that a simple and systematic Advance Care Planning intervention is
 likely to clarify the understanding of the goals of care by patients, to help with ACP
 documentation and and potentially to modify the trajectory of illness for patients during and
 after hospitalization.

ICD-10 classifications
NeoplasmsIn situ neoplasmsPersonal history of other neoplasmsBenign neoplasmsMalignant neoplasms
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06149312
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06149312 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut de cancérologie Strasbourg Europe and is currently Not yet recruiting. The study focuses on Neoplasms. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.